Related Funds
Fund Name | Location |
AT Ventures | Kyonggi-do, Seongnam, South Korea |
Beneventure Capital | Alabama, Birmingham, United States |
Borski Fund | Amsterdam, Noord-Holland, The Netherlands |
Corning | Corning, New York, United States |
Crabtree Partners | Illinois, Lake Forest, United States |
Green Harbor Investment | Chaoyang, China, Liaoning |
Honghe Erhao | - |
Kenex Holdings, LLC | Chicago, Illinois, United States |
Koray Spring | - |
KRR | - |
Nippon System Development | California, Campbell, United States |
PGE Ventures | Mazowieckie, Poland, Warsaw |
Schoolhouse Partners | Boston, Massachusetts, United States |
Sculley Brothers | New York, New York, United States |
Shenzhen Comix Holdings | China, Futian, Guangdong |
Thought into Action Entrepreneurship Institute at Colgate University | Hamilton, New York, United States |
Tianjin Weilu | China, Guangdong, Tianjin |
Z Corporation Japan | Japan, Tokyo |
Zhejiang Xinwei Information Technology | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Haina Pharmaceuticals | 16 Aug 2022 | Nanjing, Jiangsu, China | |||
Igenesis | $15M | 08 Mar 2022 | Shanghai, China | ||
KYinno | $15M | 29 Nov 2021 | Dongcheng District, Beijing, China | ||
Longhui Medical | $15M | 26 Nov 2021 | Shanghai, Shanghai, China | ||
$150M | 23 Feb 2021 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Haina Pharmaceuticals | 16 Aug 2022 | Nanjing, Jiangsu, China | |||
Igenesis | $15M | 08 Mar 2022 | Shanghai, China | ||
KYinno | $15M | 29 Nov 2021 | Dongcheng District, Beijing, China | ||
Longhui Medical | $15M | 26 Nov 2021 | Shanghai, Shanghai, China | ||
$150M | 23 Feb 2021 | Shanghai, China |